CR CNRS,
ICBMS- 3d.FAB platfrom
Director of 3D Innovation Lab, the 3D.FAB & Sartorius collaborative lab

ORCID : https://orcid.org/0000-0002-1989-4695

  • H-factor : 13
  • 25 Publications
  • 10 Patents
  • 13 Conference invitations

18 janvier 1984 (39 ans – 2 enfants)

emma.petiot@univ-lyon1.fr

SCIENTIFIC EXPERTISE

3D PRINTING : microextrusion (FDM Tobeca & Bioprinter BAB®)/ ink-jet (Pico-pulse®) / CAD Design (TSIM / Sketch-up software).

CELL CULTURE & VIROLOGY : adherent & suspension cell lines (20 cell lines : primary, continuous , MSCs cells & iPSCs) / Viruses : influenza, adenovirus, lentivirus, baculovirus.

BIOPROCESS : handling bioreactor of different scales : 10 mL to 50L / ion exchange chromatography / Diafiltration & Ultracentrifugation / Batch & Perfusion cultures.

ANALYTICS : HPLC-UPLC / RMN / LC-MS / SPRi / Cytometry / Raman & NIR spectroscopy / Capacitance spectroscopy / viral titration.

DIPLOMA

2020 Habilitation to direct research (HDR)Université Claude Bernard Lyon 1
2006 – 2009 PhD in Cell Culture and BioprocessesInstitut National Polytechnique de Lorraine (INPL) – Nancy, France (Sanofi Pasteur Colaborative Project / CNRS UMR 7274 – LRGP)
2005 – 2006 Master in Research – Catalysis and Industrial Microbiology – Ecole d’ingénieur INSA (Toulouse)
2001 – 2006 Engineering degree – Specialization in Biochemical and Food Engineering : Biochemistry and Bioprocesses – INSA Toulouse

RESEARCH GRANTS & AWARDS

2023 MITI
2022 Vaincre la Mucovicidose
2014 – 2016 Marie Curie European Individual Grant FP7 – International Incoming Fellowship (IIF)Université Claude Bernard Lyon 1, France
2010 – 2012 Natural Sciences and Engineering Research Council (NSERC) Postdoctoral GrantMontreal, Canada

ACTUAL POSITION : 2021 – PRESENT

CNRS Researcher section 54
Interdisciplinar

ICBMS-GEMBAS 3d.Fab
(UMR5246)
Oct 2021

Director of the Joint Sartorius-3d.FAB Laboratory & Head of Cell Culture and Bioprocesses activities of the 3d.FAB Platform – Scientific coordination / Internal and external training / Animation / Supervision of cell culture technicians & Master & PhD students / Maintenance of the ISO-13485 quality system for cell culture activities.

Participation or construction of academic (CIRI UMR5308, LRGP UMR7274, Ampère UMR 5005, LBTI UMR 5305) & industrial consortia (Sartorius, Pfizer US, Kaiser Endress, Ipratech).

PAST POSITIONS

Senior Researcher
ICBMS-GEMBAS
3d.Fab -UMR 5246 (France)
OCT 2020 – OCT 2021

Director of the Joint Sartorius-3d.FAB Laboratory & Head of Cell Culture and Bioprocesses activities of the 3d.FAB Platform – Maintenance of the ISO-13485 quality system for cell culture activities.

Associate Professor
CPE-Lyon- ICBMS 
3d.Fab (France)
JAN 2017 – SEPT 2020

Teaching: Head of Bioprocesses and Biotechnology Specialization Program 5th year CPE-Lyon / Co-head of Specialized Masters® in Biotechnological Process Engineering.
Research:
3D Bioprinting and Bioprocesses & Implementation of the ISO13485 quality system for cell culture activities.

Post-doctoral researcher
Laboratoire VirPath (UCBL)-Lyon (France)
Sabbatical CPE-Lyon
SEPT 2014 – DEC 2016

Marie curie FP-7 IIF European personal grant : Project and Scientific Coordination Development of a cell culture bioprocess for the production of viruses and influenza virus-like particles – McGill International Consortium, Canada / A. Star Singapore.

Associate professor
CPE-Lyon – Laboratoire VirPath (UCBL) – Lyon (France)
NOV 2013 – AUG 2014

Co-Head of a new Specialized Masters® training program in Biotechnological Process Engineering: Launch and animation of the training
Research activities: Scientific coordination of a partnership project with the company Transgene –
 Cell culture bioprocess to produce influenza virus with a new DuckCell T17TM avian cell.

Associate researcher
Biotechnology Research Institute (IRB) – National Research Center (NRC) – Montréal (Canada)
2010 – 2013

Coordination / Animation of the Influenza Vaccine Program team – Development of bioprocesses to produce viruses and influenza vaccine on cell culture (production – purification – quantification) – Participation in industrial projects: Oncolytics Biotech®/ MEDICAGO Inc. / PALL industry.

PhD Student
CNRS – Sanofi-Pasteur
Nancy/Lyon (France)
2006 – 2009

Bioprocess optimization for Sanofi Pasteur dengue vaccine production – Serum-free Vero cell culture – development of Process Analytical Technology (PAT) strategy.

TEAM MANAGEMENT

Direction of 3D Innovation Lab Joint laboratory 3d.FAB /Sartorius

Scientific program coordination: 5 scientific axis20 researchers60 m2 BSL2 ISO7 laboratory4 dedicated bioprocess Equipments

Management of 12 people over the last 6 years :

Post-Doc :

  • C. Chocarro Wrona

PhD students :

  • A. Carré
  • L. Chastagnier
  • L. Durous
  • S. Pragnere

Master students :

  • E. Cowles
  • I. Bichari
  • L. Chastagnier
  • L. Lemarié
  • O. Nicoud

Team members (Technicians, research engineers) :

  • C. Thomann
  • L. Gudimard
  • L. Essayan

SCIENTIFIC ACTIVITIES & RESPONSIBILITIES

MEMBER OF SCIENTIFIC SOCIETIES
ESACT (European Society of Animal Cell Technology)  https://esact.org/
  2019-2023 Elected member of the Executive Committee
  2014-2019 Member of the ESACT Frontiers group
MEETING & WORKSHOP ORGANIZATION
ESACT Frontiers Retreat Congress 1st ESACT Frontiers Retreat, Lyon (2015) – 115 participants- Conférence Chair
  2nd ESACT Frontiers Retreat, Zagreb (2018) – 110 participants
ESACT Frontiers Workshop  26th ESACT Meeting, Copenhagen (2019)
  25th ESACT Meeting, Lausanne (2017)
Conference of Specialized Master in Biotechnology Process Engineering (2014-2020)